Active Ingredient Aflibercept
Active Ingredient Details
What is Aflibercept?
has antiangiogenic activity; consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders
What is the usage for Aflibercept?
Aflibercept is used to treat certain serious eye conditions (such as wet age-related macular degeneration, diabetic retinopathy/macular edema, macular edema following retinal vein occlusion). This medication can help preserve vision and prevent blindness. Aflibercept belongs to a class of drugs known as growth factor inhibitors. It works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.
How many products in the NDC database contain Aflibercept?
The NDC database has 15 products with the active ingredient Aflibercept. The following table lists all the products that have this active ingredient.
NDC Products with Aflibercept
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0024-5840 | Proprietary Name: Zaltrap | Ziv-aflibercept | Solution, Concentrate | Intravenous | Sanofi-aventis U.s. Llc | ACTIVE | |
| 0024-5841 | Proprietary Name: Zaltrap | Ziv-aflibercept | Solution, Concentrate | Intravenous | Sanofi-aventis U.s. Llc | ACTIVE | |
| 55513-056 | Proprietary Name: Pavblu | Aflibercept-ayyh | Injection, Solution | Intravitreal | Amgen, Inc | ACTIVE | |
| 55513-065 | Proprietary Name: Pavblu | Aflibercept-ayyh | Injection, Solution | Intravitreal | Amgen, Inc | ACTIVE | |
| 61434-007 | Proprietary Name: | Aflibercept | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 61434-062 | Proprietary Name: | Aflibercept | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 61434-077 | Proprietary Name: | Aflibercept | Injection, Solution | Catalent Indiana, Llc | ACTIVE | ||
| 61755-005 | Proprietary Name: Eylea | Aflibercept | Injection, Solution | Intravitreal | Regeneron Pharmaceuticals, Inc. | ACTIVE | |
| 61755-050 | Proprietary Name: Eylea Hd | Aflibercept | Injection, Solution | Intravitreal | Regeneron Pharmaceuticals, Inc | ACTIVE | |
| 61755-051 | Proprietary Name: Eylea Hd | Aflibercept | Injection, Solution | Intravitreal | Regeneron Pharmaceuticals, Inc | ACTIVE | |
| 61755-905 | Proprietary Name: | Aflibercept | Injection, Solution | Regeneron Pharmaceuticals, Inc. | ACTIVE | ||
| 61755-930 | Proprietary Name: | Aflibercept | Injection, Solution | Regeneron Pharmaceuticals, Inc | ACTIVE | ||
| 61755-950 | Proprietary Name: | Aflibercept | Injection, Solution | Regeneron Pharmaceuticals, Inc. | ACTIVE | ||
| 83012-052 | Proprietary Name: | Aflibercept | Liquid | Boehringer Ingelheim Fremont, Inc. | ACTIVE | ||
| 83277-004 | Proprietary Name: | Aflibercept | Solution | Agc Biologics, Inc. | ACTIVE |